Kamel Khalili Phones & Addresses
-
440 Broad St, Philadelphia, PA 19146 (215) 761-9419
-
1900 12Th St, Philadelphia, PA 19122
-
190 Presidential Blvd UNIT 718, Bala Cynwyd, PA 19004 (215) 350-3383
-
Haverford, PA
-
516 Anthwyn Rd, Merion Station, PA 19066
-
518 Anthwyn Rd, Merion Station, PA 19066
-
Montgomery, PA
Business Records
Name / Title
Company / Classification
Phones & Addresses
Director
Temple University Health System, Inc
Social Services · Social Services Skilled Nursing Care Facility Intermediate Care Facility
Social Services · Social Services Skilled Nursing Care Facility Intermediate Care Facility
2450 W Hunting Park Ave, Philadelphia, PA 19129
(215) 707-0900
(215) 707-0900
Editor
International Society of Neurovirology
Newspapers-Publishing/Printing · Nonclassifiable Establishments
Newspapers-Publishing/Printing · Nonclassifiable Establishments
3500 N Broad St, Philadelphia, PA 19140
Principal
Polyviron, LLC
Business Services at Non-Commercial Site · Nonclassifiable Establishments
Business Services at Non-Commercial Site · Nonclassifiable Establishments
518 Anthwyn Rd, Merion Station, PA 19066
Publications
Us Patents
Method Of Cell Growth Inhibition With Agnoprotein
View pageUS Patent:
7612039, Nov 3, 2009
Filed:
Jun 11, 2003
Appl. No.:
10/517710
Inventors:
Kamel Khalili - Merion PA, US
Assignee:
Temple University - Of The Commonwealth System of Higher Education - Philadelphia PA
International Classification:
A61K 38/00
C07K 5/00
C07K 5/00
US Classification:
514 12, 530324
Abstract:
The growth of normal and abnormally proliferating cells can be inhibited by the introduction of agnoprotein, or biologically active fragments or derivatives of agnoprotein, into the cell in the absence of any other polyoma virus protein or viral replication.
Modulation Of Gsk-3Beta Activity And Its Different Uses
View pageUS Patent:
20020115635, Aug 22, 2002
Filed:
Feb 21, 2001
Appl. No.:
09/788477
Inventors:
Pnina Fishman - Herzliya, IL
Kamel Khalili - Merion PA, US
Kamel Khalili - Merion PA, US
International Classification:
A61K031/522
A61K031/52
A61K031/7076
A61K031/52
A61K031/7076
US Classification:
514/046000, 514/263340, 514/263400
Abstract:
A method for a therapeutic treatment, comprising administering to a subject in need an effective amount of an active agent for achieving a therapeutic effect, the therapeutic effect comprises modulating GSK-3B activity in cells and said active agent is selected from the group consisting of an adenosine A1 receptor ligand (A1RL), an A2 adenosine receptor ligand (A2RL), an adenosine A3 receptor ligand (A3RL) and a combination of the same.
Modulation Of Gsk-3Beta Activity And Its Different Uses
View pageUS Patent:
20020165197, Nov 7, 2002
Filed:
Feb 21, 2002
Appl. No.:
10/078712
Inventors:
Pnina Fishman - Herzliya, IL
Kamel Khalili - Merion PA, US
Kamel Khalili - Merion PA, US
International Classification:
A61K031/7076
A61K031/522
A61K031/522
US Classification:
514/046000, 514/263340
Abstract:
The present invention concerns the modulation of glycogene synthase kinase 3 (G3SK-3) by an adenosine receptor ligand. Depending on the type of ligand, the modulation may be manifested by down-regulation or up-regulation of the kinase's activity. Thus, there is provided by the present invention a method and pharmacetical compositions for achieving a therapeutic effect involved in modulating GSK-3 activity in cells by the use of an adenosine receptor ligand or a combination of ARLs. When modulation involves activation of GSK-3 activity the ARL may be an adenosine A1 receptor agonist (A1RAg), an adenosine A3 receptor agonist (A3RAg), an adenosine A2 receptor antagonist (A2RAn) or any combination of the same, while when modulation involves inhabition of GSK-3 activity the ARL may be an adenosine A1 receptor antagonist (A1RAn), an adenosine A3 receptor antagonist (A3RAn), an adenosine A2 receptor agonist (A2RAg) or any combination of the same.
Compositions And Methods For Sirna Inhibition Of Primate Polyomavirus Genes
View pageUS Patent:
20070249552, Oct 25, 2007
Filed:
May 12, 2005
Appl. No.:
11/596479
Inventors:
Kamel Khalili - Merion PA, US
Jennifer Gordon - Philadelphia PA, US
Jennifer Gordon - Philadelphia PA, US
International Classification:
A61K 31/713
A61K 31/7105
C07H 21/02
C12N 15/85
C12N 15/86
A61K 31/7105
C07H 21/02
C12N 15/85
C12N 15/86
US Classification:
514044000, 435320100, 536023100
Abstract:
RNA interference using small interfering RNAs which are specific for mRNA produced from the JCV agnoprotein and large T antigen genes inhibits expression of these and other primate polyomavirus genes. Primate polyomavirus infection, and diseases which are associated with primate polyomavirus infection, can be treated by administering the small interfering RNAs.
Use Of An Adenosine A3 Receptor Agonist For Inhibition Of Viral Replication
View pageUS Patent:
7589075, Sep 15, 2009
Filed:
Jan 13, 2002
Appl. No.:
10/466263
Inventors:
Pnina Fishman - Herzliya, IL
Kamel Khalili - Merion PA, US
Kamel Khalili - Merion PA, US
Assignee:
Can-Fite Biopharma Ltd. - Petach Tikva
International Classification:
A61K 31/52
A61K 31/522
A61K 31/7076
A61K 31/522
A61K 31/7076
US Classification:
514 45, 51426323, 5142633, 51426335, 51426336
Abstract:
The present invention concerns the use of an active ingredient selected from the group consisting of agonists of the adenosine receptor system, for inhibiting viral replication in cells. In particular, the invention provides a composition and method for inhibiting viral replication in cells, the method comprising presenting to the cells an effective amount of the active ingredient. According to one embodiment, the adenosine agonist is an A3 receptor agonist (A3RAg). The invention is particularly useful, for although not limited to, inhibiting the replication of HIV virus in human cells.
Bag3 As A Target For Therapy Of Heart Failure
View pageUS Patent:
20230073246, Mar 9, 2023
Filed:
Oct 5, 2022
Appl. No.:
17/938209
Inventors:
- PHLIDELPHIA PA, US
Douglas G. Tilley - Bryn Mawr PA, US
Weizhong Zhu - Cockeysville MD, US
Kamel Khalili - Bala Cynwyd PA, US
Walter J. Koch - Broomall PA, US
Douglas G. Tilley - Bryn Mawr PA, US
Weizhong Zhu - Cockeysville MD, US
Kamel Khalili - Bala Cynwyd PA, US
Walter J. Koch - Broomall PA, US
Assignee:
TEMPLE UNIVERSITY OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION - PHILADELPHIA PA
International Classification:
C12Q 1/6883
G01N 33/68
G01N 33/68
Abstract:
Compositions are directed to BCL2-associated athanogene 3 (BAG3) molecules and agents which modulate expression of BAG3 molecules. Pharmaceutical composition for administration to patients, for example, patients with heart failure, comprise one or more BAG3 molecules or agents which modulate expression of BAG3. Methods of treatment and identifying candidate therapeutic agents are also provided.
Anti-Flaviviridae Activity Of Anti-Retroviral Non-Nucleoside (Nnrtis) And Nucleoside Reverse Transcriptase Inhibitors (Nnrtis)
View pageUS Patent:
20210128554, May 6, 2021
Filed:
Dec 22, 2017
Appl. No.:
16/472462
Inventors:
- Philadelphia PA, US
Kamel Khalili - Bala Cynwyd PA, US
Kamel Khalili - Bala Cynwyd PA, US
International Classification:
A61K 31/505
A61P 31/14
A61K 45/06
A61P 31/14
A61K 45/06
Abstract:
Compositions of non-nucleoside reverse transcriptase inhibitor (NNRTI) and/or a nucleoside reverse transcriptase inhibitor (NRTI) or combinations thereof, in the prevention and treatment of Flaviviridae infections, e.g. Zika virus.
Bag3 As A Target For Therapy Of Heart Failure
View pageUS Patent:
20210017600, Jan 21, 2021
Filed:
May 21, 2020
Appl. No.:
15/929784
Inventors:
- Philadelphia PA, US
Douglas G. Tilley - Bryn Mawr PA, US
Weizhong Zhu - Cockeysville MD, US
Kamel Khalili - Bala Cynwyd PA, US
Walter J. Koch - Broomall PA, US
Douglas G. Tilley - Bryn Mawr PA, US
Weizhong Zhu - Cockeysville MD, US
Kamel Khalili - Bala Cynwyd PA, US
Walter J. Koch - Broomall PA, US
Assignee:
TEMPLE UNIVERSITY OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION - Philadelphia PA
International Classification:
C12Q 1/6883
G01N 33/68
G01N 33/68
Abstract:
Compositions are directed to BCL2-associated athanogene 3 (BAG3) molecules and agents which modulate expression of BAG3 molecules. Pharmaceutical composition for administration to patients, for example, patients with heart failure, comprise one or more BAG3 molecules or agents which modulate expression of BAG3. Methods of treatment and identifying candidate therapeutic agents are also provided.
Isbn (Books And Publications)
Human Polyomaviruses: Molecular and Clinical Perspectives
View page
Author
Kamel Khalili
ISBN #
0471390097
Human Polyomaviruses: Molecular and Clinical Perspectives
View page
Author
Kamel Khalili
ISBN #
0471461024
Amazon
Viral Oncology: Basic Science and Clinical Applications
View pageA comprehensive look at the latest research findings and clinical applications of oncogenic viruses Written by a panel of academic experts, Viral Oncology is the first self-contained and comprehensive book to present both scientific and clinical information on viruses linked to some of the most impo...
Author
Kamel Khalili, Kuan-Teh Jeang
Binding
Hardcover
Pages
491
Publisher
Wiley-Blackwell
ISBN #
047037991X
EAN Code
9780470379912
ISBN #
1
Viral Oncology: Basic Science and Clinical Applications by Kamel Khalili (2009-11-23)
View page
Author
Kamel Khalili;Kuan-Teh Jeang
Binding
Hardcover
Publisher
Wiley-Blackwell
ISBN #
12
Viral Oncology: Basic Science and Clinical Applications by Kamel Khalili (2009-11-23)
View page
Author
Kamel Khalili; Kuan-Teh Jeang;
Binding
Hardcover
Publisher
Wiley-Blackwell; 1 edition (2009-11-23)
ISBN #
11
[(Viral Oncology: Basic Science and Clinical Applications)] [Author: Kamel Khalili] published on (March, 2010)
View page
Binding
Hardcover
Publisher
Wiley-Blackwell (an imprint of John Wiley & Sons Ltd)
ISBN #
10
[(Human Polyomaviruses: Molecular and Clinical Perspectives)] [Author: Kamel Khalili] published on (October, 2001)
View page
Binding
Hardcover
Publisher
John Wiley & Sons Inc
ISBN #
9
Human Polyomaviruses: Molecular and Clinical Perspectives [HARDCOVER] [2002] [By Kamel Khalili]
View page
Binding
Hardcover
Publisher
Wiley-Liss
ISBN #
8
Viral Oncology: Basic Science and Clinical Applications 1st edition by Khalili, Kamel; Jeang, Kuan-Teh published by Wiley-Blackwell Hardcover
View page
Binding
Hardcover
Publisher
Wiley-Blackwell
ISBN #
3
Human Polyomaviruses: Molecular and Clinical Perspectives
View pageHuman PolyomavirusesMolecular and Clinical perspectivesEdited by Kamel Khalili and Gerald L. StonerOur understanding of human polyomaviruses has evolved profoundly in the last fifteen years, creating an urgent need for an updated resource. Drs. Khalili and Stoner have collected the contributions of ...
Author
Kamel Khalili, Gerald L. Stoner
Binding
Hardcover
Pages
696
Publisher
Wiley-Liss
ISBN #
0471390097
EAN Code
9780471390091
ISBN #
2